Literature DB >> 21087345

Simultaneous operation of concomitant diseases in the esophagus and lung.

Y Zhu1, Q Pu, Lin Ma, J Mei, L Chen, G Che, Z Wu, L Liu.   

Abstract

The aim of this study was to retrospectively review our experience of performing simultaneous operations on concomitant diseases in the esophagus and lungs. From January 1998 to July 2009, simultaneous operations were performed on 13 patients with concomitant esophageal and pulmonary diseases, using coordinated surgical approaches. Among the 13 patients, six had primary cancers in the esophagus and lungs, five had primary esophageal cancer accompanied by a benign pulmonary disease, one had benign diseases in both esophagus and lung, and one had primary esophageal cancer with metastasis to the left lower lung. All patients survived the operations. Two major complications occurred postoperatively. One complication was bronchopleural fistula and the other was intrathoracic gastric laceration. Both patients recovered after additional treatments. Simultaneous operation of concomitant diseases in the esophagus and lungs is feasible and safe in selected patients who have received careful preoperative assessment, well-designed surgical approach, and proper perioperative management.
© 2010 Copyright the Authors. Journal compilation © 2010, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Year:  2010        PMID: 21087345     DOI: 10.1111/j.1442-2050.2010.01139.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  2 in total

1.  Simultaneous pneumonectomy and esophagectomy in an elderly patient.

Authors:  Chenglin Guo; Jiandong Mei; Hu Liao; Chengwu Liu; Qiang Pu; Lin Ma; Lunxu Liu
Journal:  Thorac Cancer       Date:  2014-03-03       Impact factor: 3.500

2.  Clinical significance of incidental pulmonary nodules in esophageal cancer patients.

Authors:  Amin Madani; Jonathan Spicer; Thierry Alcindor; Marc David; Marie Vanhuyse; Jamil Asselah; David Mulder; Lorenzo Ferri
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.